SEC Form 4 · accession 0001209191-15-024050
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Carey
Officer — EVP & Chief Business Officer
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 3:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Mar 5, 2015 | M | 31,025 | — | A | 32,981 | D | |
| Ordinary Shares | Mar 5, 2015 | F | 9,736 | $20.84 | D | 23,245 | D | |
| Ordinary Shares | holding | — | — | — | 57,655 | I | By Robert F. Carey III Trust dated 4/24/2001 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Mar 5, 2015 | M | 31,025 | D | — | — | Ordinary Shares | 31,025 | 93,075 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2Includes 1,956 ordinary shares of the Issuer acquired by the reporting person on November 30, 2014 pursuant to an employee stock purchase program
- F3On March 5, 2014, the reporting person was granted 124,100 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.